FeesSafety
Pluang+

Ascentage Pharma CEO Dr. Dajun Yang ranks No. 3 on The Medicine Maker Power List 2026 for small molecules.

Others
27 Jul 2026, 02:30 WIB
GlobeNewsWire
View Source
Bullish
Ascentage Pharma CEO Dr. Dajun Yang ranks No. 3 on The Medicine Maker Power List 2026 for small molecules.

Dr. Dajun Yang, Chairman and CEO of Ascentage Pharma, was named No. 3 in the Small Molecules category on The Medicine Maker Power List 2026, recognizing his leadership in innovative cancer drug development. Under his guidance, Ascentage Pharma has advanced novel therapies like olverembatinib and lisaftoclax, addressing unmet medical needs in cancer treatment. The company is conducting multiple global Phase III trials and has achieved dual stock listings in Hong Kong and the U.S. Dr. Yang’s recognition highlights Ascentage’s impact on global oncology innovation and its commitment to developing new cancer therapies.

More News

DeGen Medical moves to dismiss Carlsmed's patent suit over spinal implant methods.

DeGen Medical moves to dismiss Carlsmed's patent suit over spinal implant methods.

DeGen Medical has filed a motion to dismiss key parts of a patent infringement lawsuit from Carlsmed, which claims DeGen's patient-specific spinal implants infringe on eight patents. DeGen argues that the contested patents cover abstract, computer-im...

Market News
Neutral
2 hours ago
SoFi projects 50% earnings growth in 2027 and no need for new capital raises.

SoFi projects 50% earnings growth in 2027 and no need for new capital raises.

SoFi announced it expects about 50% growth in earnings for 2027, signaling strong financial performance ahead. The company also stated it will not need to raise new capital, indicating confidence in its current funding and business model. This outloo...

Company Fundamentals
Bullish
3 hours ago
Bitcoin open interest stayed stable as price dropped from $83K to $74K, hinting at ongoing leverage risks.

Bitcoin open interest stayed stable as price dropped from $83K to $74K, hinting at ongoing leverage risks.

Bitcoin's open interest remained nearly unchanged during its price drop from $83,000 to $74,000, indicating that leveraged positions continued to be added despite the falling price. When Bitcoin's price later fell to around $65,000, open interest dec...

Market News
Neutral
5 hours ago
Aster investigates unusual ASTER token volatility amid leveraged liquidations and possible malicious activity.

Aster investigates unusual ASTER token volatility amid leveraged liquidations and possible malicious activity.

Aster's CEO announced the team is investigating a sudden and unusual price swing in the ASTER token. The volatility is primarily attributed to liquidations of highly leveraged positions, but the CEO also mentioned the possibility of malicious activit...

Market News
Neutral
5 hours ago
Fifteen stocks raised dividends; TSM and VRT lead with big increases, while some cuts and concerns emerge.

Fifteen stocks raised dividends; TSM and VRT lead with big increases, while some cuts and concerns emerge.

Fifteen stocks recently announced dividend increases, signaling confidence in their cash flow, with TSM and VRT raising dividends by 28.57% and 60%, respectively. MZTI offers a 3.78% yield and upside potential, while COST declared a $30 special divid...

Company Fundamentals
Neutral
5 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App